Rational use of plasma protein and tissue binding data in drug design
- PMID: 25099658
- DOI: 10.1021/jm5007935
Rational use of plasma protein and tissue binding data in drug design
Abstract
It is a commonly accepted assumption that only unbound drug molecules are available to interact with their targets. Therefore, one of the objectives in drug design is to optimize the compound structure to increase in vivo unbound drug concentration. In this review, theoretical analyses and experimental observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concentration. Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concentration. Instead, low intrinsic clearance leads to high in vivo unbound plasma concentration, and low efflux transport activity at the blood-brain barrier leads to high unbound brain concentration. Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.
Similar articles
-
Do we need to optimize plasma protein and tissue binding in drug discovery?Curr Top Med Chem. 2011;11(4):450-66. doi: 10.2174/156802611794480918. Curr Top Med Chem. 2011. PMID: 21320069 Review.
-
[Blood plasma proteins and drug transport across the hemato-encephalic barrier].Farmakol Toksikol. 1991 Jan-Feb;54(1):70-6. Farmakol Toksikol. 1991. PMID: 1860509 Review. Russian.
-
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.J Pharmacol Exp Ther. 2005 Jun;313(3):1254-62. doi: 10.1124/jpet.104.079319. Epub 2005 Mar 2. J Pharmacol Exp Ther. 2005. PMID: 15743928
-
Use of unbound volumes of drug distribution in pharmacokinetic calculations.Eur J Pharm Sci. 2011 Jan 18;42(1-2):91-8. doi: 10.1016/j.ejps.2010.10.011. Epub 2010 Nov 2. Eur J Pharm Sci. 2011. PMID: 21050885
-
QSAR analysis of blood-brain distribution: the influence of plasma and brain tissue binding.J Pharm Sci. 2011 Jun;100(6):2147-60. doi: 10.1002/jps.22442. Epub 2011 Jan 26. J Pharm Sci. 2011. PMID: 21271563
Cited by
-
Anti-Alopecia Activity of Alkaloids Group from Noni Fruit against Dihydrotestosterone-Induced Male Rabbits and Its Molecular Mechanism: In Vivo and In Silico Studies.Pharmaceuticals (Basel). 2022 Dec 14;15(12):1557. doi: 10.3390/ph15121557. Pharmaceuticals (Basel). 2022. PMID: 36559008 Free PMC article.
-
Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.J Med Chem. 2020 Jul 9;63(13):6847-6862. doi: 10.1021/acs.jmedchem.0c00225. Epub 2020 Jun 17. J Med Chem. 2020. PMID: 32469516 Free PMC article.
-
Interpretation of Drug Interaction Using Systemic and Local Tissue Exposure Changes.Pharmaceutics. 2020 May 2;12(5):417. doi: 10.3390/pharmaceutics12050417. Pharmaceutics. 2020. PMID: 32370191 Free PMC article. Review.
-
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.J Med Chem. 2018 Dec 27;61(24):11349-11371. doi: 10.1021/acs.jmedchem.8b01578. Epub 2018 Dec 11. J Med Chem. 2018. PMID: 30468386 Free PMC article.
-
Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.Antibiotics (Basel). 2022 Jul 8;11(7):923. doi: 10.3390/antibiotics11070923. Antibiotics (Basel). 2022. PMID: 35884177 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources